Lorena Tavano

Dr. Lorena Tavano

Department Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Arcavacata di Rende (CS)-Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Biomaterials
Verified
Journal Article
Open access
Daniele Rubert Nogueira-LibrelottoDaniele Rubert Nogueira-Librelotto
Daniele Rubert Nogueira-Librelotto
LTLorena Tavano
Lorena Tavano
MAMontse Mitjans Arnal
Montse Mitjans Arnal
LPLourdes Perez
Lourdes Perez
MIM. Rosa Infante
M. Rosa Infante
MVM. Pilar Vinardell
M. Pilar Vinardell
Nanoparticles with pH-sensitive behavior may enhance the success of chemotherapy in many cancers by efficient intracellular drug delivery. Here, we investigated the effect of a bioactive surfactant with pH-sensitive properties on the antitumor activity and intracellular behavior of methotrexate-loaded chitosan nanoparticles (MTX-CS-NPs). NPs were prepared using a modified ionotropic complexation process, in which was included the surfactant derived from N(α),N(ε)-dioctanoyl lysine with an inorganic lithium counterion. The pH-sensitive behavior of NPs allowed accelerated release of MTX in an acidic medium, as well as membrane-lytic pH-dependent activity, which facilitated the cytosolic delivery of endocytosed materials. Moreover, our results clearly proved that MTX-CS-NPs were more active against the tumor HeLa and MCF-7 cell lines than the free drug. The feasibilty of using NPs to target acidic tumor extracellular pH was also shown, as cytotoxicity against cancer cells was greater in a mildly acidic environment. Finally, the combined physicochemical and pH-sensitive properties of NPs generally allowed the entrapped drug to induce greater cell cycle arrest and apoptotic effects. Therefore, our overall results suggest that pH-sensitive MTX-CS-NPs could be potentially useful as a carrier system for tumor and intracellular drug delivery in cancer therapy.

1 February 2014 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
LTLorena Tavano
Lorena Tavano
Rita  MuzzalupoRita Muzzalupo
Rita Muzzalupo
NPNevio Picci
Nevio Picci
BCBruno de Cindio
Bruno de Cindio

1 September 2011 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Rita  MuzzalupoRita Muzzalupo
Rita Muzzalupo
LTLorena Tavano
Lorena Tavano
RCRoberta Cassano
Roberta Cassano
Sonia TrombinoSonia Trombino
Sonia Trombino
TFTeresa Ferrarelli
Teresa Ferrarelli
NPNevio Picci
Nevio Picci

1 October 2013 in Langmuir
Verified
Journal Article
Closed access
LTLorena Tavano
Lorena Tavano
Rita  MuzzalupoRita Muzzalupo
Rita Muzzalupo
LMLoredana Mauro
Loredana Mauro
MPMichele Pellegrino
Michele Pellegrino
SASebastiano Andò
Sebastiano Andò
NPNevio Picci
Nevio Picci

1 October 2011 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
LTLorena Tavano
Lorena Tavano
PAPasquale Alfano
Pasquale Alfano
Rita  MuzzalupoRita Muzzalupo
Rita Muzzalupo
BCBruno de Cindio
Bruno de Cindio

1 February 2014 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
LTLorena Tavano
Lorena Tavano
Rita  MuzzalupoRita Muzzalupo
Rita Muzzalupo
NPNevio Picci
Nevio Picci
BCBruno de Cindio
Bruno de Cindio